4//SEC Filing
Stanker James H 4
Accession 0001567619-22-018057
CIK 0001533743other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:51 PM ET
Size
5.5 KB
Accession
0001567619-22-018057
Insider Transaction Report
Form 4
Stanker James H
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-06-30−23,947→ 326,713 totalExercise: $0.00→ Common Stock (23,947 underlying)
Footnotes (1)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001681718
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:51 PM ET
- Size
- 5.5 KB